文献速递外周动脉疾病

严重肢体缺血合并感染患者一期与分期截肢结局对比

Results of One-Stage or Staged Amputations of Lower Limbs Consequent to Critical Limb Ischemia and Infection.
PubMed 文献 · Ann Vasc Surg · 2017-07-06

该回顾性研究分析2004—2011年185例严重肢体缺血(CLI)截肢患者,比较一期截肢(OSA)与分期截肢(SA)的技术成功率和死亡率。SA的技术成功率更高(77.2% vs 66.0%,P=0.0253),围手术期死亡率(10.9% vs 20.7%,P=0.0247)和30天死亡率(12.2% vs 23.8%,P=0.0220)更低,尽管SA组Rutherford 5-6级、糖尿病和感染比例更高。

要点

  • SA技术成功率77.2%,高于OSA的66.0%(P=0.0253)。
  • SA围手术期死亡率10.9%,低于OSA的20.7%(P=0.0247)。
  • SA组缺血更重、糖尿病和感染更多,但结局仍更优。

核心结论

  • SA的技术成功率高于OSA,且围手术期死亡率和30天死亡率更低。
  • 尽管SA组糖尿病、Rutherford 5-6级和感染比例更高,结局仍优于OSA。
  • 需前瞻性研究进一步比较两种截肢技术。

研究设计与样本

  • 回顾性研究,纳入2004—2011年185例连续CLI截肢患者。
  • 共分析101例SA(91例患者)和106例OSA(94例患者)。
  • 主要终点为技术成功率(愈合无裂开或再干预)和死亡率,采用logistic回归分析影响因素。

主要发现

  • SA技术成功率77.2%,OSA为66.0%(P=0.0253)。
  • SA围手术期死亡率10.9%,OSA为20.7%(P=0.0247)。
  • SA 30天死亡率12.2%,OSA为23.8%(P=0.0220)。
  • SA组Rutherford 5-6级占87.1%,OSA组72.6%(P=0.0047)。
  • SA组糖尿病占71.2%,OSA组55.6%(P=0.0076);SA组感染占44.5%,OSA组28.3%(P=0.0061)。

关键数值与推荐

  • SA成功相关因素:非胰岛素治疗的糖尿病(P=0.0072)、股动脉截肢(P=0.0392)、无冠心病(P=0.0053)、足部感染(P=0.0446)。
  • OSA成功相关因素:非糖尿病(P=0.0077)、无感染(P=0.0298)、足部截肢(P=0.0155)、股动脉截肢(P=0.0030)。

临床怎么用

  • 对CLI合并感染、糖尿病等高危患者,SA可能提高技术成功率并降低死亡率。
  • 选择截肢方式时需综合评估糖尿病状态、感染部位、截肢平面和冠心病史。

局限性

  • 回顾性研究设计,可能存在选择偏倚。
  • 需前瞻性研究进一步验证两种技术的优劣。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amputations of lower limbs can be conducted as one-stage amputation (OSA) or staged amputation (SA) procedures. The objective of this study was to analyze technical success and mortality rates of both techniques, as well as factors that might influence outcomes in patients with critical limb ischemia (CLI). METHODS: A retrospective study of 185 consecutive patients with CLI who underwent amputations in the period 2004-2011. Primary end points were rates of technical success (healing without dehiscence or reintervention) and mortality. The influence on outcomes of demographic data, clinical status, and comorbidities was also analyzed by logistic regression. RESULTS: A total of 101 SA (91 patients) and 106 OSA (94 patients) were analyzed. SA had proportionally higher success rate (SA 77.2% vs. OSA 66.0%, P = 0.0253), lower perioperative mortality rate (SA, 10.9% vs. OSA, 20.7%, P = 0.0247), and lower 30-day mortality rate (SA, 12.2% vs. OSA, 23.8%, P = 0.0220) in spite of more cases with Rutherford classes 5 and 6 (SA, 87.1% vs. OSA, 72.6%, P = 0.0047), diabetes (71.2% vs. 55.6%, P = 0.0076), and infection (44.5% vs. 28.3%, P = 0.0061). Logistic regression demonstrated that in SA, success was more frequent in patients with diabetes who did not use insulin (P = 0.0072), in those with transfemoral amputations (P = 0.0392), with no coronary artery disease (P = 0.0053), and in foot infection (P = 0.0446), while for OSA success was more frequent in nondiabetic patients (P = 0.0077), limbs without infection (P = 0.0298), amputations at foot level (P = 0.0155), or transfemoral amputations (P = 0.0030). CONCLUSIONS: SA had a higher rate of technical success and lower mortality rates than OSA, even with greater number of patients with diabetes and more severe cases of ischemia and infection. However, prospective studies comparing both techniques are needed for further evidence.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Silva LR, Fernandes GM, Morales NU, et al. Results of One-Stage or Staged Amputations of Lower Limbs Consequent to Critical Limb Ischemia and Infection. Ann Vasc Surg. 2017. PMID: 28689936. doi:10.1016/j.avsg.2017.06.144

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。